Search research articles
Contact Us
Filters
Showing results (221-230 of 358) with videos related to
Page
of 36
Sort By:
Biorxiv : the Preprint Server for Biology
|
August 14, 2023
Mis-splicing Drives Loss of Function of p53<sup>E224D</sup> Point Mutation
Ian C Lock, Nathan H Leisenring, Warren Floyd, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 9, 2010
Imaging primary lung cancers in mice to study radiation biology
David G Kirsch, Jan Grimm, Alexander R Guimaraes, et al.
Life Sciences in Space Research
|
August 11, 2015
Concepts and challenges in cancer risk prediction for the space radiation environment
Mary Helen Barcellos-Hoff, Eleanor A Blakely, Sandeep Burma, et al.
The Journal of Clinical Investigation
|
September 29, 2020
Tumor genotype dictates radiosensitization after Atm deletion in primary brainstem glioma models
Katherine Deland, Bryce F Starr, Joshua S Mercer, et al.
Ebiomedicine
|
February 4, 2019
Investigating a chimeric anti-mouse PDGFRα antibody as a radiosensitizer in primary mouse sarcomas
Erin J Song, Kathleen A Ashcraft, Caitlin D Lowery, et al.
Cell Stem Cell
|
July 13, 2010
Primary tumor genotype is an important determinant in identification of lung cancer propagating cells
Stephen J Curtis, Kerstin W Sinkevicius, Danan Li, et al.
Journal of Thoracic Disease
|
September 15, 2025
Outcomes and prognostic factors in primary intrathoracic soft tissue sarcoma
Siyer Roohani, Nattinee Wattakiyanon, Charles Catton, et al.
Cold Spring Harbor Symposia on Quantitative Biology
|
July 28, 2006
Mouse models of human non-small-cell lung cancer: raising the bar
C F B Kim, E L Jackson, D G Kirsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2016
Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials
C Norman Coleman, Geoff S Higgins, J Martin Brown, et al.
Molecular Cancer Therapeutics
|
April 8, 2024
A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors
Tona M Gilmer, Chun-Hsiang Lai, Kexiao Guo, et al.
Page
of 36
Search research articles
Search
Showing results (221-230 of 358) with videos related to
Sort By:
Page
of 36
Biorxiv : the Preprint Server for Biology
|
August 14, 2023
Mis-splicing Drives Loss of Function of p53<sup>E224D</sup> Point Mutation
Ian C Lock, Nathan H Leisenring, Warren Floyd, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 9, 2010
Imaging primary lung cancers in mice to study radiation biology
David G Kirsch, Jan Grimm, Alexander R Guimaraes, et al.
Life Sciences in Space Research
|
August 11, 2015
Concepts and challenges in cancer risk prediction for the space radiation environment
Mary Helen Barcellos-Hoff, Eleanor A Blakely, Sandeep Burma, et al.
The Journal of Clinical Investigation
|
September 29, 2020
Tumor genotype dictates radiosensitization after Atm deletion in primary brainstem glioma models
Katherine Deland, Bryce F Starr, Joshua S Mercer, et al.
Ebiomedicine
|
February 4, 2019
Investigating a chimeric anti-mouse PDGFRα antibody as a radiosensitizer in primary mouse sarcomas
Erin J Song, Kathleen A Ashcraft, Caitlin D Lowery, et al.
Cell Stem Cell
|
July 13, 2010
Primary tumor genotype is an important determinant in identification of lung cancer propagating cells
Stephen J Curtis, Kerstin W Sinkevicius, Danan Li, et al.
Journal of Thoracic Disease
|
September 15, 2025
Outcomes and prognostic factors in primary intrathoracic soft tissue sarcoma
Siyer Roohani, Nattinee Wattakiyanon, Charles Catton, et al.
Cold Spring Harbor Symposia on Quantitative Biology
|
July 28, 2006
Mouse models of human non-small-cell lung cancer: raising the bar
C F B Kim, E L Jackson, D G Kirsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2016
Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials
C Norman Coleman, Geoff S Higgins, J Martin Brown, et al.
Molecular Cancer Therapeutics
|
April 8, 2024
A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors
Tona M Gilmer, Chun-Hsiang Lai, Kexiao Guo, et al.
Page
of 36